In a virtual media briefing next Tuesday, May 16, at 11:30 a.m. EDT, noted infectious disease expert Mark Rupp, M.D. will detail the results of a forthcoming journal publication on a new device.
The School of Oncoplastic Surgery (SOS), which zeroes in on the growing trend toward oncoplastic breast-conserving surgery, will hold its next training program Jan. 27-29, 2017.
Steven Schonholz, MD, FACS, will present a scientific poster on how BioZorb is used in the treatment of breast cancer at the 32nd Annual Miami Breast Cancer Conference, in Miami Beach, Fla., Feb. 26 to March 1.
The use of disinfection caps is included in major new infection-control recommendations sponsored by the Society for Healthcare Epidemiology of America (SHEA) and other top infection-control organizations.
There are substantial differences between the results provided by Agendia’s breast cancer genomic tests and more limited results from the 21-gene assay, according to findings presented at the recently concluded ASCO meeting.
A research study led by cancer specialists at MedStar Washington Hospital Center found that African-American women frequently present with biologically less favorable subtypes of breast cancer.
Jason Patric, the actor (best known for his roles in Lost Boys and Speed 2: Cruise Control) and activist, who is fighting to be an equal parent, will join three nationally known parenting experts in a virtual media conference Wednesday, June 4, the week leading up to Father’s Day.
New evidence showing that the MammaPrint® and BluePrint® tests provide insights into how to treat breast cancer was presented at the annual conference of the American Society of Breast Surgeons (ASBrS).
The BioZorb™ three-dimensional surgical marker improved the ability of radiation oncologists to target radiation treatment for breast cancer, according to a scientific presentation at the 2014 American Brachytherapy Society (ABS) Annual Meeting.
A method called molecular subtyping can help doctors better determine which of their breast cancer patients are at high risk of getting breast cancer again, a new study led by the University of South Florida reports.
Simply replacing the connector in the IV system in patients with central lines could help reduce deadly bloodstream infections, researchers at Georgia Regents University have found.
Molecular subtyping can help predict outcomes and chemotherapy benefit in patients with colorectal cancer, according to a presentation at the annual conference of the American Society of Clinical Oncology (ASCO).
Research on different types of IV connectors led a Johns Hopkins cancer center to pilot a “neutral pressure” IV connector, according to a scientific presentation at the annual meeting of the Oncology Nursing Society (ONS).
The MammaPrint breast cancer test can dramatically reduce the number of women who need to undergo chemotherapy to treat the disease, according to a newly published study.
Patients at NorthShore University HealthSystem are now better protected against potentially deadly infections, according to a newly published study.
A California hospital reported that its vascular access team has gone nearly seven years without a central line-associated bloodstream infection (CLABSI) in any of its peripherally inserted central catheter (PICC) lines.
The latest generation of genomic tests for breast cancer can improve physicians’ ability to diagnose the disease and more precisely tailor each patient’s treatment, according to a study being presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).
The American Society of Breast Disease (ASBD) is merging art and medicine this week, by using clay sculpting and other techniques to teach surgeons new skills in breast cancer surgery and reconstruction.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right